United States · FDA National Drug Code directory
Budesonide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0093-6815_551a929a-3517-4e58-9df6-f9bfb0f2f3be
- Product NDC
- 0093-6815
- Form
- SUSPENSION
- Composition / generic term
- Budesonide
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190111
- Source listing expiry
- 20261231
Source-listed ingredients
- BUDESONIDE — .25 mg/2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 POUCH in 1 CARTON (0093-6815-55) / 1 VIAL, SINGLE-DOSE in 1 POUCH / 2 mL in 1 VIAL, SINGLE-DOSE · 0093-6815-55
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →